NJ State Employees Deferred Compensation Plan’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,000
Closed -$250K 493
2023
Q2
$250K Hold
6,000
0.04% 407
2023
Q1
$248K Hold
6,000
0.04% 407
2022
Q4
$247K Hold
6,000
0.04% 394
2022
Q3
$263K Hold
6,000
0.05% 382
2022
Q2
$295K Hold
6,000
0.05% 360
2022
Q1
$340K Hold
6,000
0.05% 372
2021
Q4
$315K Hold
6,000
0.04% 392
2021
Q3
$359K Hold
6,000
0.05% 359
2021
Q2
$407K Hold
6,000
0.05% 344
2021
Q1
$393K Hold
6,000
0.06% 348
2020
Q4
$338K Hold
6,000
0.05% 351
2020
Q3
$291K Hold
6,000
0.05% 330
2020
Q2
$334K Hold
6,000
0.06% 301
2020
Q1
$304K Hold
6,000
0.07% 281
2019
Q4
$464K Hold
6,000
0.08% 289
2019
Q3
$380K Hold
6,000
0.07% 319
2019
Q2
$351K Hold
6,000
0.06% 372
2019
Q1
$341K Sell
6,000
-3,000
-33% -$159K 0.06% 392
2018
Q4
$446K Buy
+9,000
New +$541K 0.09% 257

Other funds holding NUVA

NJ State Employees Deferred Compensation Plan's NUVA Position: Q3 2023 in Review

NJ State Employees Deferred Compensation Plan sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 6,000 shares — an estimated $250K sold.

NJ State Employees Deferred Compensation Plan first reported a position in NUVA in Q4 2018 and held it in 19 quarters. The position peaked at $464K in Q4 2019. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • NJ State Employees Deferred Compensation Plan reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 6,000 NuVasive, Inc. shares in Q3 2023, an estimated $250K.
  • NJ State Employees Deferred Compensation Plan first reported a position in NuVasive, Inc. in Q4 2018 and held it in 19 quarters.
  • NJ State Employees Deferred Compensation Plan's NuVasive, Inc. position peaked at $464K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2023, filed 8 Nov 2023.